Thats why, when choosing products to use, I always make sure to be extra careful & check all the ingredients
(R-KS) sent a bipartisan letter to the FDA flagging Hims & Hers' ad and accusing the company of misleading patients "by omitting any safety or side effect information when promoting a specific type of weight loss medication." Under federal law and regulations, FDA requires that prescription drug advertisements be truthful, not misleading, and balancedfailure to do so risks FDA enforcement action, including civil monetary penalties, Durbin and Marshall said in the letter
The Rise of Telehealth and Fragmented Diabetes Care Apr 9, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 1,116 views Telehealth prescribing of GLP-1 medications is rapidly reshaping how diabetes and weight management care is delivered
There have been anecdotal reports that GLP-1 medications may contribute to anorexia by blunting hunger cues for people whove developed an unhealthy aversion to food
Thank you for watching